Tulla...I think it will be a disgraceful thing to turn this down...it has previous clinicals behind it...it passed so many tests...there are mgmt/advisory with strong backgrounds who have worked years to move this forward...the drug involved has already been approved by FDA and cell in box causes no immune response...I am still thinking that FDA needs more time to understand how this works and to study the tests and previous clinical results...30 days seems not enough time and so we have this hold...